Slides: Inflammation as potential target for therapy to target residual risk post ACS
Slides prepared and presented by prof Paul M Ridker, MD - Brigham and Women’s Hospital, Harvard Medical School, Boston, USA - at the PACE-CME symposium held at ESC 2016 in Rome, Italy
View presentation slides
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
Share this page with your colleagues and friends: